Glycemic variability and mortality in critically ill patients: higher risk in non-diabetic patients

Objective: Glycemic variability (GV) is associated with increased morbidity and mortality in critically ill patients. This study aimed to contribute to the knowledge on the subject and to investigate the situation in our intensive care patient population. Method: Patients who were admitted to the Intensive Care Unit (ICU) between January 2015 and August 2020 were screened using the hospital’s database. The following data were collected: demographic characteristics of the patients, comorbidities, APACHE II scores, SOFA scores, mean amplitude of glycemic excursions (MAGE) based on daily blood glucose measurements from the first day of ICU admission until discharge up to the 28th day of their stay, length of stay (LOS), and 28-day mortality status. Results: In this study, 136 patients were enrolled and divided into high (n=70) and low GV (n=66). No differences were found between the two groups in terms of age, gender, comorbidity, APACHE II, mean SOFA scores, treatments, ICU LOS, and mortality. MAGE was higher in nonsurvivors (78.8 ±32.2) compared to survivors (65.4 ±22.5) (t=-2.78, p= 0.005). Regarding the mortality, the AUC value for GV was 0.611 (p=0.02) for MAGE >61 mg/dl, with a sensitivity of 68.5% and specificity of 50%. Patients were grouped according to GV (MAGE>65) and the presence of diabetes mellitus (DM). Mortality was highest in patients with high GV and without DM (53.3%). Conclusion: In this study, MAGE levels were higher in non-survivors than survivors, and glycemic variability was moderately associated with mortality. Patients with high GV and without DM had a higher mortality rate compared to those with DM.

• Publication year

  2025

• Venue

  Turkish Journal of Intensive Care

• Publication date

  2025-09-05

• Fields of study

  Not labeled

• Identifiers
  DOI 10.63729/tjic.2025.662
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Glycemic Variability As a Prognostic Factor for Mortality in Patients With Critical Illness: A Systematic Review and Meta-Analysis

  2024cited by this paper
• Glycemic variability in critically ill patients: risk factors and association with mortality.

  2020cited by this paper
• Higher glycemic variability within the first day of ICU admission is associated with increased 30-day mortality in ICU patients with sepsis

  2020cited by this paper
• Fuentes

  2020cited by this paper
• Glycemic variability: prognostic impact on acute ischemic stroke and the impact of corrective treatment for hyperglycemia. The GLIAS-III translational study

  2020cited by this paper
• Different Indexes of Glycemic Variability as Identifiers of Patients with Risk of Hypoglycemia in Type 2 Diabetes Mellitus

  2018cited by this paper
• 6. Glycemic Targets: Standards of Medical Care in Diabetes—2018

  2017cited by this paper
• Metabolic Management during Critical Illness: Glycemic Control in the ICU

  2015cited by this paper
• The prevalence of undiagnosed diabetes mellitus and the association of baseline glycemic control on mortality in the intensive care unit: a prospective observational study.

  2014cited by this paper
• Glycaemic variability, infections and mortality in a medical-surgical intensive care unit.

  2014cited by this paper
• Moderate glucose control is associated with increased mortality compared with tight glucose control in critically ill patients without diabetes.

  2013cited by this paper
• Stress hyperglycemia: an essential survival response!

  2013cited by this paper
• Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients

  2012cited by this paper
• Glucose variability measures and their effect on mortality: a systematic review

  2011cited by this paper
• Hypoglycemia and outcome in critically ill patients.

  2010cited by this paper
• Glycemic Variability and Mortality in Critically 111 Patients: The Impact of Diabetes

  2009cited by this paper
• Intensive versus conventional glucose control in critically ill patients.

  2009cited by this paper
• Glycemic variability: A strong independent predictor of mortality in critically ill patients*

  2008cited by this paper
• Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

  2006cited by this paper
• Association of Hypoglycemia, Hyperglycemia, and Glucose Variability With Morbidity and Death in the Pediatric Intensive Care Unit

  2006cited by this paper
• Hyperglycaemia in critically ill patients: marker or mediator of mortality?

  2006cited by this paper
• The pathobiology of diabetic complications: a unifying mechanism.

  2005cited by this paper
• Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.

  2003cited by this paper
• Intensive insulin therapy in critically ill patients.

  2002cited by this paper
• The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure

  1996cited by this paper
• APACHE II: a severity of disease classification system.

  1985cited by this paper
• APACHE II: A severity of disease classification system

  1985cited by this paper
• Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability

  1970cited by this paper

• Diabetes Mellitus Is an Independent Predictor of Short-Term Mortality in Critically Ill ICU Patients.

  2026cites this paper